Eman Abdel-Wahab | Mechanism of Resistance | Best Researcher Award

Published on by Infectious

Assoc. Prof. Dr. Eman Abdel-Wahab | Mechanism of Resistance | Best Researcher Award

Senior Researcher | Agricultural Research Center | Egypt

Dr. Eman Ibrahim El-Sayed Abdel-Wahab is a distinguished Senior Researcher in Genetics at the Agricultural Research Center (ARC), Giza, Egypt, recognized for her expertise in plant genetics, crop improvement, and sustainable agricultural systems. Since joining ARC in 2012, she has conducted extensive research on the genetic and molecular mechanisms underlying soybean resistance to pests such as the cotton leaf worm (Spodoptera littoralis) and lima bean pod borer (Etiella zinckenella), while also advancing knowledge in intercropping systems, legume productivity, water use efficiency, and biotic stress tolerance. She has authored or co-authored over 50 scientific publications, including journal papers, book chapters, and conference proceedings published by Springer, IGI Global, and Lambert Academic Publishing, with her research achieving 33 citations across 10 Scopus-indexed documents and an h-index of 4. Actively contributing to national research programs focused on enhancing food legume production, Dr. Abdel-Wahab has played a vital role in strengthening Egypt’s agricultural resilience and sustainability. In addition to her research, she has served as a reviewer and editorial board member for several international journals, earning more than 30 certificates of excellence in reviewing from reputed publishers. Her outstanding achievements have been recognized globally through honors such as the World Championship in Seed Yield (Soybean Varieties) and the Agricultural Management Fellowship from India. Through her pioneering work on genetic resistance mechanisms and crop development, Dr. Abdel-Wahab continues to make a lasting impact on agricultural innovation, food security, and sustainable farming systems.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Metwally, A. E. A., Safina, S., Abdel-Wahab, E., & Abdel-Wahab, S. (2021). Screening thirty soybean genotypes under solid and intercropping plantings in Egypt. Journal of Crop Science and Biotechnology, 24, 203–220.

Safina, S., Mohamed, H., Abdel-Wahab, E., & El-Moemen, M. (2018). Seed yield and its quality of some soybean varieties as affected by humic acid. Academia Journal of Agricultural Research, 6(5), 194–213.

Abdel-Wahab, E., Naroz, M., & Abd El-Rahman, S. (2019). Potential of some soybean varieties for resistance to lima bean pod borer (Etiella zinckenella) under field conditions. Research on Crops, 20(2), 389–398.

Abdel-Wahab, S., & Abdel-Wahab, E. (2020). Competitive and facilitative effects of intercropping some soybean varieties with corn under different soybean plant densities. Plant Archives, 20(2), 1631–1639.

Dr. Eman Ibrahim El-Sayed Abdel-Wahab’s research significantly advances sustainable agriculture by improving soybean productivity, pest resistance, and intercropping efficiency through genetic and molecular innovation. Her work enhances food security, optimizes land use in resource-limited environments, and supports the development of resilient crop systems vital for global agricultural sustainability.

Goran Augustin | Abdominal infections | Best Researcher Award

Published on by Infectious

Dr. Goran Augustin | Abdominal infections | Best Researcher Award 

MD, PhD | University Hospital Centre Zagreb | Croatia

Dr. Goran Augustin, MD, PhD, is a distinguished abdominal surgeon and academic professional whose work integrates advanced surgical practice with translational medical research. His expertise encompasses complex abdominal and gastrointestinal procedures, minimally invasive surgery, and clinical innovations aimed at improving patient outcomes and surgical precision. Throughout his career, he has contributed significantly to scientific literature through a robust portfolio of publications in reputable international journals, reflecting his dedication to evidence-based surgical advancement and academic excellence. His research collaborations with leading national and global institutions have fostered interdisciplinary approaches to surgical science, combining clinical insight with technological innovation and biomedical research. As an advocate for global health and surgical education, Dr. Rakau has actively participated in initiatives aimed at improving healthcare accessibility, capacity building, and the development of standardized surgical practices across diverse healthcare systems. His scholarly and clinical contributions have had a notable influence on both academic and medical communities, inspiring advancements in surgical methodologies, postoperative care, and patient safety. Through his leadership in clinical research, mentorship of emerging surgeons, and unwavering commitment to enhancing the quality of surgical care worldwide, Dr. Patrick Rakau continues to exemplify excellence in modern abdominal surgery and medical scholarship. He has 6061 citations from 179 documents with an h-index of 36.

Profiles: Google Scholar | Scopus | ORCID

Publications

1. Age Is Not So Important for Risk Stratification in Early Cholecystectomy for Acute Calculous Cholecystitis: A Post-Hoc Analysis of the SPRiMACC Study Database. (2025). Medicina (Lithuania).

2. Anticoagulation management and outcomes in critically ill patients with acute mesenteric ischemia: An international study. (2025). Intensive Care Medicine.

3. Protective ileostomy creation after anterior resection of the rectum (PICARR): A decision-making exploring international survey. (2025). Updates in Surgery.

4. A Survey on the Management of Patients with Severe Traumatic Brain Injury During Pregnancy: The MAMA Study. (2025). Neurocritical Care.

5. Phase angle as a prognostic biomarker in metastatic colorectal cancer: A prospective trial. (2025). World Journal of Experimental Medicine.

JungWoo Shin | Microbial Pathogenesis | Best Researcher Award

Published on by Infectious

Mr. JungWoo Shin | Microbial Pathogenesis | Best Researcher Award

Master’s degree | KyungHee University | South Korea

Prof. Jung-Woo Shin is an accomplished researcher in the field of biomedical and pharmaceutical sciences, currently completing his M.S. at the College of Pharmacy, KyungHee University , following a B.S. in Biomedical & Medical and Pharmaceutical Materials with a double major from Hallym University . His professional experience encompasses extensive work on the modulation of gut microbiota and the therapeutic potential of probiotics, including Lactococcus lactis, Bifidobacterium longum, and Lactobacillus plantarum, in alleviating gastrointestinal disorders, neuroinflammation, liver injury, fibrosis, and anxiety- and depression-like behaviors in preclinical mouse models. Prof. Shin’s research interests focus on the intersection of microbiology, immunology, neuropharmacology, and translational therapeutics, particularly in understanding the mechanisms by which gut microbiota and probiotic interventions influence systemic and neurological health via pathways such as NF-κB, AMPK signaling, and IL-6 regulation. His research skills include in vivo modeling, molecular biology techniques, microbiome analysis, histopathology, and behavioral assays, as reflected in his publications in high-impact journals such as Letters in Applied Microbiology, Journal of Microbiology and Biotechnology, and Microbes and Infection. Prof. Shin has been recognized for his contributions to the field through various academic awards and honors during his graduate and undergraduate studies. He continues to advance innovative probiotic-based therapeutic strategies with translational potential for human health, aiming to bridge basic research and clinical application. His work has garnered significant recognition, with 2,427 citations , 94 published works, and an h-index of 26, underscoring his impactful contribution to biomedical research and the scientific community.

Profiles : Google Scholar | Scopus | ORCID

  1. Park, S. Y., Park, C., Seo, J., & Shin, J. (2025). Public willingness to pay for chemical regulation in South Korea: The case of restriction on arsenic use. Environment, Development and Sustainability, 27(5), 11509–11526.
    Citations: 2
  2. Oh, M., Moon, H. B., Woo, J. R., Kim, H., & Shin, J. (2024). How to be a winner of future vehicle maintenance services: Consumer preference for vehicle self-diagnosis and fault prediction system in next-generation vehicles. Technology Analysis & Strategic Management, 1–13.
    Citations: 2
  3. Hong, Y., Shin, J., Choi, H., & Ahn, J. W. (2024). Investigating the value of parallel pipeline projects for water supply: A contingent valuation study in South Korea. Water, 16(6), 819.
    Citations: 2
  4. Kim, K., Shin, J., & Choi, J. Y. (2017). Impact analysis of economic contributors on knowledge creation activity by using the symmetric decomposition method. Symmetry, 9(11), 251.
    Citations: 2
  5. Kang, C., Lee, C., Zhao, X., Lee, D., Shin, J., & Lee, J. (2025). Safety still matters: Unveiling the value propositions of augmented reality head-up displays in autonomous vehicles through conjoint analysis. Travel Behaviour and Society, 39, 100915.
    Citations: 1

Mr. Silas Adjei-Gyamfi | Infectious diseases | Best Researcher Award

Published on by Infectious

Mr. Silas Adjei-Gyamfi | Infectious diseases | Best Researcher Award

Auckland University of Technology | New Zealand.

Author Profile

Scopus

Orcid

🎓EARLY ACADEMIC PURSUITS

Mr. Silas Adjei–Gyamfi began his academic journey with a profound interest in microbiology and infectious diseases, laying a strong foundation in biomedical science. His early studies were marked by academic excellence and scientific curiosity, leading him to pursue specialized training in pathogen biology, clinical microbiology, and molecular epidemiology.

💼PROFESSIONAL ENDEAVORS

Mr. Adjei–Gyamfi has consistently bridged the gap between theory and practice, applying his scientific expertise in a variety of clinical, research, and public health settings. His roles have included positions in academic laboratories, national health institutes, and international health organizations, where he has contributed to infectious disease diagnostics, control, and policy formulation.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON INFECTIOUS DISEASES

A core focus of Mr. Adjei–Gyamfi’s career has been on infectious disease surveillance, diagnostics, and prevention. His contributions span several critical areas:

  • Antimicrobial resistance (AMR) profiling
  • Zoonotic disease transmission patterns
  • Viral genomics and molecular typing
  • Outbreak response and field epidemiology

He is recognized for implementing innovative diagnostic technologies, such as real-time PCR, serological assays, and pathogen genome sequencing, to improve early detection and containment of outbreaks.

🌍IMPACT AND INFLUENCE

Mr. Adjei–Gyamfi’s research and leadership have directly influenced public health responses to infectious disease threats in sub-Saharan Africa and beyond. He has played instrumental roles in cross-border health initiatives, community-level disease education, and data-driven decision-making in epidemic control.

🏆RESEARCH GRANTS AND FUNDING

Mr. Adjei–Gyamfi has successfully secured competitive research funding from national and international agencies, including:

  • World Health Organization (WHO) initiatives
  • Global Fund-supported projects
  • National Institutes of Health (NIH) collaborations
  • Africa CDC and regional grants

These funds have supported capacity-building in diagnostics, community surveillance programs, and field research into infectious disease ecology.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Looking forward, Mr. Adjei–Gyamfi aims to build sustainable health research systems in low-resource settings. His future initiatives include:

  • Establishing infectious disease reference centers

  • Developing AI-driven surveillance platforms

  • Training young scientists in Africa in biosecurity and epidemiology

🌟A VISIONARY IN INFECTIOUS DISEASES

Mr. Silas Adjei–Gyamfi embodies the spirit of innovation, resilience, and service in the infectious disease field. With a career marked by scientific integrity, collaborative leadership, and community-centered approaches, he continues to shape health outcomes at local and global levels.

📑NOTABLE PUBLICATIONS

Knowledge and occupational practices of beauticians and barbers in the transmission of viral hepatitis: A mixed-methods study in Volta Region of Ghana

Authors: Adjei-Gyamfi, Silas; Asirifi, Abigail; Asobuno, Clotilda; Korang, Felix Kwame
Year: 2025
Journal: PLoS ONE

Risk factors for anaemia among pregnant women: A cross-sectional study in Upper East Region, Ghana

Authors: Asobuno, C.; Adjei-Gyamfi, S.; Aabebe, F.G.; Hammond, J.; Taikeophithoun, C.; Amunah, N.; Aoki, T.; Aiga, H.
Year: 2024
Journal: PLoS ONE​

Anaemia at 36 weeks of pregnancy: Prevalence and determinants among antenatal women attending peri-urban facilities in a developing country, Ghana

Authors: Adjei-Gyamfi, S.; Asirifi, A.; Peprah, W.; Abbey, D.A.; Hamenoo, K.W.; Zakaria, M.S.; Mohammed, O.; Aryee, P.A.
Year: 2024
Journal: PLOS Global Public Health

Maternal anaemia and polycythaemia during pregnancy and risk of inappropriate birthweight for gestational age babies: A retrospective cohort study in the northern belt of Ghana

Authors: Adjei-Gyamfi, S.; Zakaria, M.S.; Asirifi, A.; Sulley, I.; Ibrahim, M.A.; Aryee, P.A.
Year: 2024
Journal: BMJ Open

Prevalence and associated risk factors of preterm and post-term births in Northern Ghana: A retrospective study in Savelugu Municipality

Authors: Adjei-Gyamfi, S.; Asirifi, A.; Aiga, H.
Year: 2023
Journal: Journal of Pediatrics, Perinatology and Child Health

Yi HSin Wang | Antibiotic | Best Researcher Award

Published on by Infectious

Yi HSin Wang | Antibiotic | Best Researcher Award

Assist Prof Dr. Yi HSin Wang , Chung Shan Medical University, Taiwan.

Assist Prof Dr. Yi Hsin Wang is a dedicated researcher specializing in antibiotic discovery and development. With a strong academic foundation in microbiology and pharmacology, she has contributed significantly to the understanding of antibiotic resistance mechanisms and the identification of novel antimicrobial agents. Her work focuses on developing innovative strategies to combat bacterial infections, making a profound impact on public health. Yi Hsin has published numerous articles in peer-reviewed journals and has presented her research at international conferences, showcasing her commitment to advancing the field of antibiotic research. Her dedication to scientific excellence and her contributions to antibiotic development make her a deserving candidate for the Best Researcher Award.

Profile:

Scopus  Profile

Education

Assist Prof Dr. Yi-Hsin Wang pursued his academic journey at Chung Shan Medical University, beginning with a Bachelor of Science degree in Medical Applied Chemistry from 2008 to 2012. He then advanced to the Institute of Medicine at the same university, completing a Master of Science degree from 2012 to 2014 under the guidance of Professors Jinghua Tsai Chang and Shiang-Suo Huang. Building upon his research foundation, Yi-Hsin continued his studies in the Institute of Medicine, where he earned his Ph.D. from 2014 to 2018, with Professors Jinghua Tsai Chang and Shiang-Suo Huang as his advisors once again.

 

Experience 

Assist Prof Dr. Yi-Hsin Wang currently holds the position of Assistant Professor in the Department of Physiology at Chung Shan Medical University’s School of Medicine (2022.08–present). Previously, Wang served as a Postdoctoral Researcher in the Department of Pharmacology at China Shan Medical University’s School of Medicine (2019.08–2022.07) and in the Graduate Institute of Acupuncture Science at China Medical University (2018.09–2019.07), with a strong focus on physiology, pharmacology, and acupuncture science throughout their academic and research career.

 

Skills

Assist Prof Dr. Yi-Hsin Wang possesses a range of experimental skills, including expertise in creating animal models for myocardial infarction and ischemic stroke. Additionally, Wang is proficient in Western blotting, gelatin zymography, and immunohistochemistry, each essential for analyzing protein expression, enzyme activity, and tissue-specific antigen localization.

 

Awards

Assist Prof Dr. Yi-Hsin Wang has received notable awards for contributions to biomedical sciences, including the Young Scientist Travel Award at the 9th FAOPS Congress (2019) in Japan and 2nd place in the Poster Award at the 33rd Joint Annual Conference of Biomedical Sciences (2018) in Taiwan.

 

Research Skills

Assist Prof Dr. Yi-Hsin Wang research expertise encompasses a diverse range of fields, including cardiology, with a focus on cardioprotection, and extends to neuroscience, particularly in the area of neuroprotection. His work also addresses the mechanisms underlying ischemia/reperfusion injury, contributing to a deeper understanding of both brain and cardiovascular physiology.

Top Note Publications

Title: Dunaliella salina Alga Protects against Myocardial Ischemia/Reperfusion Injury by Attenuating TLR4 Signaling

Authors: Tsai, C.-F., Lin, H.-W., Liao, J.-M., … Wang, M., Huang, S.-S.
Year: 2023
Citations: 4

Title: Lumbrokinase Regulates Endoplasmic Reticulum Stress to Improve Neurological Deficits in Ischemic Stroke

Authors: Wang, Y.-H., Liao, J.-M., Chen, K.-M., … Tsai, C.-F., Huang, S.-S.
Year: 2022
Citations: 5

Title: Activation of Peripheral TRPM8 Mitigates Ischemic Stroke by Topically Applied Menthol

Authors: Huang, S.-S., Su, H.-H., Chien, S.-Y., … Lee, H.-H., Chen, Y.-H.
Year: 2022
Citations: 14

Title: In Situ Slow-Release Recombinant Growth Differentiation Factor 11 Exhibits Therapeutic Efficacy in Ischemic Stroke

Authors: Su, H.-H., Yen, J.-C., Liao, J.-M., … Chen, Y.-H., Huang, S.-S.
Year: 2021
Citations: 5

Title: Paeonol Protects Against Myocardial Ischemia/Reperfusion-Induced Injury by Mediating Apoptosis and Autophagy Crosstalk

Authors: Tsai, C.-F., Su, H.-H., Chen, K., … Wang, Y.-H., Huang, S.-S.
Year: 2021
Citations: 27

Introduction of Antibiotic

Published on by Infectious

Introduction of Antibiotic

Antibiotics are powerful medications used to treat infections caused by bacteria. They work by killing bacteria or inhibiting their growth, helping to cure infections that would otherwise become severe or life-threatening. Antibiotics have revolutionized modern medicine since their discovery, drastically reducing mortality from bacterial infections. However, the misuse and overuse of antibiotics have led to increasing levels of antibiotic resistance, posing a significant threat to global health.

  • Types of Antibiotics:
  1. Broad-spectrum Antibiotics:
    These antibiotics work against a wide variety of bacteria, both Gram-positive and Gram-negative. Examples include:

    • Amoxicillin
    • Tetracycline
    • Ciprofloxacin
  2. Narrow-spectrum Antibiotics:
    These antibiotics target specific types of bacteria. Examples include:

    • Penicillin G (used mainly against Gram-positive bacteria)
    • Vancomycin (used against resistant Gram-positive bacteria)
  3. Bactericidal Antibiotics:
    These kill bacteria by attacking their cell walls or vital cellular functions. Examples include:

    • Penicillin
    • Cephalosporins
    • Aminoglycosides
  4. Bacteriostatic Antibiotics:
    These inhibit bacterial growth by interfering with bacterial protein production or DNA replication. Examples include:

    • Tetracycline
    • Sulfonamides
    • Chloramphenicol
  • How Antibiotics Work:
  • Antibiotics target key processes in bacteria that are essential for their survival and replication. These include:
  • Cell wall synthesis inhibition: Prevents bacteria from forming cell walls, leading to cell death (e.g., Penicillin).
  • Protein synthesis inhibition: Disrupts bacterial ribosomes, which produce proteins essential for cell function (e.g., Tetracycline).
  • DNA replication inhibition: Prevents bacterial DNA replication, halting cell division (e.g., Quinolones).
  • Cell membrane disruption: Damages bacterial cell membranes, leading to cell death (e.g., Polymyxins).

    Examples of Antibiotic-Resistant Bacteria:

    1. Methicillin-resistant Staphylococcus aureus (MRSA): Resistant to many antibiotics, causing serious skin infections.
    2. Vancomycin-resistant Enterococci (VRE): Often found in hospital-acquired infections.
    3. Carbapenem-resistant Enterobacteriaceae (CRE): Highly resistant to most antibiotics and often fatal.
    4. Multidrug-resistant Mycobacterium tuberculosis (MDR-TB): Resistant to the two most powerful anti-TB drugs, requiring complex and prolonged treatment.
  • Understanding and managing animal infectious diseases is crucial for animal health, public health, and maintaining food security.

 

Introduction of Animal Infectious Diseases
Introduction of Animal infectious diseases Animal infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites that can affect a wide range of animal species.